Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research
Where Will Gabapentin ’s Bumpy Road Lead us? A Narrative Review of Pediatric Perioperative Gabapentinoids
AbstractPurpose of ReviewGabapentinoids, including gabapentin and pregabalin, have been commonly administered in the perioperative period since opioid-sparing effects were found in adults in the early 2000s. This review examines the current evidence for and against the perioperative use of gabapentinoids in children and identifies potential future directions for research.Recent FindingsMany factors led to increasing use of gabapentinoids for surgical patients. The national opioid epidemic hastened the move toward the use of multimodal analgesia and early recovery after surgery protocols for both adults and children. Howeve...
Source: Current Anesthesiology Reports - November 7, 2023 Category: Anesthesiology Source Type: research
